PPI - Radically Pragmatic
  • Donate
Skip to content
  • Home
  • About
    • About Us
    • Locations
    • Careers
  • People
  • Projects
  • Our Work
  • Events
  • Donate

People

Robert Popovian

Senior Health Policy Fellow

Dr. Robert Popovian is the Founder of the strategic consulting firm Conquest Advisors. He previously served as Vice President, U.S. Government Relations at Pfizer. One of the country’s foremost experts on every significant facet of biopharmaceuticals and the healthcare industry, he is also a recognized authority on health economics, policy, government relations, medical affairs, and strategic planning.

Dr. Popovian has published extensively on the impact of biopharmaceuticals and health policies on costs and clinical outcomes in the most prominent medical sources and media publications, including the Clinical Economics and Outcomes Research, The Oncologist, Journal of Vaccines and Vaccinations, Health Science Journal, USA Today, Managed Healthcare Executive and Morning Consult. He is also a sought-after speaker and has been invited to provide detailed presentations, briefings, and expert reviews for the U.S. Congress, dozens of state legislatures, and at conferences and medical symposiums throughout the country and around the world.

He is one of the select few researchers to study and publish both clinical and policy-related economic analysis as well as empirical data regarding emerging payment models in the U.S. healthcare system and for biopharmaceutical reimbursement. His insight and analysis also led to one of the first inclusions of health outcomes data regarding a biopharmaceutical labeled indication.

Dr. Popovian was recently appointed as the Chief Science Policy Officer for Global Healthy Living Foundation. He also serves on the Board of Councilors of University of Southern California School of Pharmacy, Member of the National Board of Prior Authorization Specialists Executive Committee, and Board of Advisors for ConsenSys Health. Robert completed his Doctorate in Pharmacy and Master of Science in Pharmaceutical Economics and Policy degrees at the University of Southern California with honors.  He has also completed a residency in Pharmacy Practice/Adult Internal Medicine and Infectious Diseases at the Los Angeles County-USC Hospital and a fellowship in Pharmaceutical Economics and Policy at USC.

Robert and his family have residences in Los Angeles, CA, and Washington, DC.

 

Recent Work

Op-Ed  |  August 17, 2023

Popovian for Clinical Leader: Patients Need Faster Access To Approved FDA Vaccines. What Can We Do?

  • Robert Popovian
Op-Ed  |  May 12, 2023

Popovian, Delaney, and Mandel for Medium: Are we on the cusp of a new drug pricing paradigm?

  • Robert Popovian Erin Delaney Michael Mandel
Op-Ed  |  April 4, 2023

Popovian for InsideSources: A Federal Drug Discount Program for the Wealthy

  • Robert Popovian
Op-Ed  |  February 28, 2023

Popovian for National Review: Transparency Laws Are the First Step toward Creating a More Sustainable Health-Care System

  • Robert Popovian
Op-Ed  |  February 7, 2022

Popovian for Inside Sources: We Need to Avert the Next Public Health Disaster

  • Robert Popovian
Op-Ed  |  October 27, 2021

Popovian for Outsourced Pharma: Benefit Design In Medicare Exacerbates Vaccine Access Inequity

  • Robert Popovian
  • Never miss an update:

  • Subscribe to our newsletter
PPI Logo
  • Twitter
  • LinkedIn
  • Facebook
  • Donate
  • Careers
  • © 2025 Progressive Policy Institute. All Rights Reserved.
  • |
  • Privacy Policy
  • |
  • Privacy Settings